文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

肺炎相关急性呼吸窘迫综合征患者支气管肺泡灌洗中的混合感染与死亡率:一项前瞻性观察性研究

Coinfection and Mortality in Pneumonia-Related Acute Respiratory Distress Syndrome Patients with Bronchoalveolar Lavage: A Prospective Observational Study.
PubMed 文献 · Shock · 2017-01-01
一句话结论肺炎相关ARDS患者经BAL检出病毒合并其他病原体混合感染时,医院死亡率(80.5%)显著高于仅检出病毒者(53.7%)。

该研究为长庚纪念医院2012年10月至2015年5月的前瞻性观察性研究,纳入符合柏林定义的肺炎相关ARDS成人患者,且在气管吸出物或痰中未明确病原体时行BAL检查。19936例筛查患者中902例(4.5%)符合柏林定义,其中255例(22.7%)为肺炎相关ARDS并纳入分析。142例(55.7%)经BAL检出病原体,分为仅病毒组(n=41,28.9%)、无病毒组(n=60,42.2%)和混合感染组(n=41,28.9%)。三组ARDS严重程度无显著差异(P=0.43)。医院死亡率分别为仅病毒组53.7%、无病毒组63.3%、混合感染组80.5%,混合感染组显著高于仅病毒组(80.5% vs 53.7%;P=0.01)。

要点

  • 肺炎相关ARDS患者经BAL检出病毒合并其他病原体混合感染时,医院死亡率80.5%,显著高于仅检出病毒者的53.7%(P=0.01)。
  • 经BAL检出病原体的患者(55.7%)医院死亡率有高于病原体阴性患者的趋势。
  • 三组间ARDS严重程度无显著差异(P=0.43),提示死亡率差异并非由ARDS严重度解释。
  • BAL检查适用于临床怀疑肺炎相关ARDS且气管吸出物或痰未明确病原体的成人患者。

适用人群与场景

  • 成人患者,符合柏林定义ARDS,临床怀疑肺炎相关ARDS,且气管吸出物或痰中未明确微生物样本(BAL指征)。
  • 研究地点为长庚纪念医院,时间2012年10月至2015年5月。

诊断标准与关键阈值

  • ARDS诊断采用柏林定义。
  • BAL指征:临床怀疑肺炎相关ARDS且气管吸出物或痰中未明确微生物样本。

研究设计与关键结果

  • 研究类型:前瞻性观察性研究;筛查19936例,902例(4.5%)符合柏林定义,255例(22.7%)肺炎相关ARDS纳入分析。
  • 142例(55.7%)经BAL检出病原体,分为仅病毒组(n=41,28.9%)、无病毒组(n=60,42.2%)、混合感染组(n=41,28.9%)。
  • 三组ARDS严重程度无显著差异(P=0.43)。
  • 医院死亡率:仅病毒组53.7%,无病毒组63.3%,混合感染组80.5%;混合感染组显著高于仅病毒组(80.5% vs 53.7%;P=0.01)。
  • 经BAL病原体阳性患者医院死亡率有高于病原体阴性患者的趋势。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在肺炎相关ARDS成人患者中,若气管吸出物或痰未明确病原体,行BAL检查可识别病毒合并其他病原体的混合感染,该类患者医院死亡率更高(80.5% vs 仅病毒组53.7%)。
  • 作者认为,病毒与另一种病原体混合感染与肺炎相关ARDS患者医院死亡率增加相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Pneumonia is the leading risk factor of acute respiratory distress syndrome (ARDS). It is increasing studies in patients with pneumonia to reveal that coinfection with viral and bacterial infection can lead to poorer outcomes than no coinfection. This study evaluated the role of coinfection identified through bronchoalveolar lavage (BAL) examination on the outcomes of pneumonia-related ARDS.

METHODS: We performed a prospective observational study at Chang Gung Memorial Hospital from October 2012 to May 2015. Adult patients were included if they met the Berlin definition of ARDS. The indications for BAL were clinically suspected pneumonia-related ARDS and no definite microbial sample identified from tracheal aspirate or sputum. The presence of microbial pathogens and clinical outcomes were analyzed.

RESULTS: Of the 19,936 patients screened, 902 (4.5%) fulfilled the Berlin definition of ARDS. Of these patients, 255 (22.7%) had pneumonia-related ARDS and were included for analysis. A total of 142 (55.7%) patients were identified to have a microbial pathogen through BAL and were classified into three groups: a virus-only group (n = 41 [28.9%]), no virus group (n = 60 [42.2%]), and coinfection group (n = 41 [28.9%]). ARDS severity did not differ significantly between the groups (P = 0.43). The hospital mortality rates were 53.7% in virus-only identified group, 63.3% in no virus identified group, and 80.5% in coinfection identified group. The coinfection group had significantly higher mortality than virus-only group (80.5% vs. 53.7%; P = 0.01).

CONCLUSION: In patients with pneumonia-related ARDS, the BAL pathogen-positive patients had a trend of higher mortality rate than pathogen-negative patients. Coinfection with a virus and another pathogen was associated with increased hospital mortality in pneumonia-related ARDS patients.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kao KC, Chiu LC, Hung CY, et al. Coinfection and Mortality in Pneumonia-Related Acute Respiratory Distress Syndrome Patients with Bronchoalveolar Lavage: A Prospective Observational Study. Shock. 2017. PMID: 28410546. doi:10.1097/SHK.0000000000000802

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。